235 related articles for article (PubMed ID: 27285846)
21. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
[TBL] [Abstract][Full Text] [Related]
22. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of the Number of Retrieved Lymph Nodes in Pathological Nx or N0 Classical Papillary Thyroid Carcinoma.
Sung TY; Yoon JH; Song DE; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ
World J Surg; 2016 Aug; 40(8):2043-50. PubMed ID: 26952113
[TBL] [Abstract][Full Text] [Related]
25. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
26. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
Kim WW; Park HY; Jung JH
Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
Zhang L; Liu H; Xie Y; Xia Y; Zhang B; Shan G; Li X
Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of oncological outcomes and quality of life after robotic versus conventional open thyroidectomy with modified radical neck dissection in patients with papillary thyroid carcinoma and lateral neck node metastases.
Lee J; Kwon IS; Bae EH; Chung WY
J Clin Endocrinol Metab; 2013 Jul; 98(7):2701-8. PubMed ID: 23678034
[TBL] [Abstract][Full Text] [Related]
29. Propensity score-matched analysis of robotic versus endoscopic bilateral axillo-breast approach (BABA) thyroidectomy in papillary thyroid carcinoma.
Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
Langenbecks Arch Surg; 2017 Mar; 402(2):243-250. PubMed ID: 27774578
[TBL] [Abstract][Full Text] [Related]
30. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
31. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
32. A Comparison of Robotic Versus Open Thyroidectomy for Papillary Thyroid Cancer.
Paek SH; Kang KH; Park SJ
Surg Laparosc Endosc Percutan Tech; 2018 Jun; 28(3):170-173. PubMed ID: 29668666
[TBL] [Abstract][Full Text] [Related]
33. Recurrence pattern after conservative surgery for papillary thyroid carcinoma.
Kobayashi K; Takenouchi S; Mitani H; Yoshida T
Auris Nasus Larynx; 2014 Dec; 41(6):548-51. PubMed ID: 24976169
[TBL] [Abstract][Full Text] [Related]
34. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
36. Surgical completeness of robotic thyroidectomy: a prospective comparison with conventional open thyroidectomy in papillary thyroid carcinoma patients.
Lee S; Lee CR; Lee SC; Park S; Kim HY; Son H; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS; Cho A
Surg Endosc; 2014 Apr; 28(4):1068-75. PubMed ID: 24221277
[TBL] [Abstract][Full Text] [Related]
37. Central neck dissection using a bilateral axillo-breast approach for robotic thyroidectomy: comparison with conventional open procedure after propensity score matching.
Kim BS; Kang KH; Kang H; Park SJ
Surg Laparosc Endosc Percutan Tech; 2014 Feb; 24(1):67-72. PubMed ID: 24487161
[TBL] [Abstract][Full Text] [Related]
38. Impact of microscopic extra-nodal extension (ENE) on locoregional recurrence following curative surgery for papillary thyroid carcinoma.
Lang BH; Shek TW; Wan KY
J Surg Oncol; 2016 Apr; 113(5):526-31. PubMed ID: 26792294
[TBL] [Abstract][Full Text] [Related]
39. Trans-oral robotic surgery and surgeon-performed trans-oral ultrasound for intraoperative location and excision of an isolated retropharyngeal lymph node metastasis of papillary thyroid carcinoma.
Goepfert RP; Liu C; Ryan WR
Am J Otolaryngol; 2015; 36(5):710-4. PubMed ID: 25964171
[TBL] [Abstract][Full Text] [Related]
40. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
